ArticleJMIR cardio2020
The Added Value of In-Hospital Tracking of the Efficacy of Decongestion Therapy and Prognostic Value of a Wearable Thoracic Impedance Sensor in Acutely Decompensated Heart Failure With Volume Overload: Prospective Cohort Study.
Article in JMIR cardio, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 2 syntheses or guidelines pooled it, 25 citations in OpenAlex.
- Wearable Devices Based on Bioimpedance Test in Heart Failure: Clinical Relevance: Systematic Review.Reviews in cardiovascular medicine · 2024Pooled it
- Bioimpedance Indices of Fluid Overload and Cardiorenal Outcomes in Heart Failure and Chronic Kidney Disease: a Systematic Review.Journal of cardiac failure · 2022Pooled it
- Mouse model for sensitivity of fluid measurement with textile electrodes.Biomedical engineering online · 2026Article
- Non-Invasive Wearable Technology to Predict Heart Failure Decompensation.Journal of clinical medicine · 2025Review
- A scoping review on advancements in noninvasive wearable technology for heart failure management.NPJ digital medicine · 2024Article
- Wearable Devices Based on Bioimpedance Test in Heart-Failure: Design Issues.Reviews in cardiovascular medicine · 2024Review
- Day-to-Day Variability in Measurements of Respiration Using Bioimpedance from a Non-Standard Location.Sensors (Basel, Switzerland) · 2024Article
- Digital Health Technologies for Post-Discharge Care after Heart Failure Hospitalisation to Relieve Symptoms and Improve Clinical Outcomes.Journal of clinical medicine · 2023Review
- Assessment of Volume Status in Hospitalized Patients With Chronic Heart Failure.Cardiology research · 2023Review
- Wearables in Nephrology: Fanciful Gadgetry or Prêt-à-Porter?Sensors (Basel, Switzerland) · 2023Review
- Artificial intelligence and digital health for volume maintenance in hemodialysis patients.Hemodialysis international. International Symposium on Home Hemodialysis · 2022Review
- Wearable Bioimpedance Monitoring: Viewpoint for Application in Chronic Conditions.JMIR biomedical engineering · 2021Article
- Noninvasive Bioimpedance Methods From the Viewpoint of Remote Monitoring in Heart Failure.JMIR mHealth and uHealth · 2021Article
- Congestive nephropathy: a neglected entity? Proposal for diagnostic criteria and future perspectives.ESC heart failure · 2021Review
- Prediction of heart failure hospitalizations based on the direct measurement of intrathoracic impedance.ESC heart failure · 2020Article
- Towards personalized fluid monitoring in haemodialysis patients: thoracic bioimpedance signal shows strong correlation with fluid changes, a cohort study.BMC nephrology · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIncomplete relief of congestion in acute decompensated heart failure (HF) is related to poor outcomes. However, congestion can be difficult to evaluate, stressing the urgent need for new objective approaches. Due to its inverse correlation with tissue hydration, continuous bioimpedance monitoring might be an effective method for serial fluid status assessments.
objectiveThis study aimed to determine whether in-hospital bioimpedance monitoring can be used to track fluid changes (ie, the efficacy of decongestion therapy) and the relationships between bioimpedance changes and HF hospitalization and all-cause mortality.
methodsA wearable bioimpedance monitoring device was used for thoracic impedance measurements. Thirty-six patients with signs of acute decompensated HF and volume overload were included. Changes in the resistance at 80 kHz (R
resultsDuring hospitalization, R
conclusionsThe wearable bioimpedance device was able to track changes in fluid status during hospitalization and is a convenient method to assess the efficacy of decongestion therapy during hospitalization. Patients who do not show an improvement in thoracic impedance tend to have worse clinical outcomes, indicating the potential use of thoracic impedance as a prognostic parameter.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.